|
445 Society urged
not to set rules for medicines displays Two
organisations representing pharmacy companies have told the Royal Pharmaceutical
Society not to be prescriptive about how medicines are displayed for
sale in pharmacies
PJ 2007;278:445
Full Text
445 NPA opposes reclassifying pseudoephedrine Proposals
to restrict pseudoephedrine and ephedrine to prescription supply in order
to prevent methylamphetamine abuse becoming a problem in the UK are based
on false grounds, the National Pharmacy Association has told a Parliamentary
inquiry into the plan
PJ 2007;278:445
Full Text
445 Monitoring of P medicines sales needs to
improve The proposed reclassification of pseudoephedrine
and ephedrine demonstrates that the monitoring of sales of pharmacy-only medicines
needs to improve, Roger Walker, consultant in pharmaceutical public health at
the National Public Health Service for Wales, says in a letter published this
week
PJ 2007;278:445
Full Text
446 MPs' committee slams NPfIT Questions
remain over the National Programme for IT and urgent action is needed at the
highest level if the long-term interests of NHS patients and taxpayers are to
be protected. So said Edward Leigh, chairman of the House of Commons Committee
of Public Accounts, as it published a report this week into progress made by
the Department of Health in implementing the programme
PJ 2007;278:446
Full Text
446 Voice messaging to be built into dispensary
system Pharmacists will be able to generate automatic
voicemail messages for patients to tell them their prescription is ready or to
remind them of a medicines use review appointment following an agreement between
Message Dynamics and Cegedim Rx
PJ 2007;278:446
Full Text
446 New NICE work programme announced Clinical
guidelines on eight further topics are to be produced by the National Institute
for Health and Clinical Excellence
PJ 2007;278:446
Full Text
446 Pharmacist pleads guilty to Society staff
assault Pharmacist Samuel Edwin Ashby faces a possible
jail sentence after pleading guilty to assault causing actual bodily harm on
being told that he was to be struck off the Register of Pharmaceutical Chemists
PJ 2007;278:446
Full Text
447 Consultation on POM to
P naproxen switch launched The number of medicines
that women can buy over the counter to treat period pain may soon increase with
the launch last week of a consultation on naproxen's switch from POM to P status
PJ 2007;278:447
Full Text
447 Two-phase design for Scotland’s chronic
medication service Scotland's chronic medication
service (CMS) will be structured in two phases, it was announced this week. CMS
is one of the four core services in the new community pharmacy contract
PJ 2007;278:447
Full Text
447 PCC issues obesity guidance A
framework for managing obesity in primary care has been published by NHS Primary
Care Contracting this week
PJ 2007;278:447
Full Text
447 Wales sets clock to improve care of chronic
conditions Medicines management for people with
chronic conditions needs to improve within three years, the Welsh Assembly Government
has said
PJ 2007;278:447
Full Text
447 Early PPI use for bleeding ulcers Early
intravenous infusion of a high-dose proton pump inhibitor before endoscopy is
justified, having a therapeutic effect on bleeding ulcers, say researchers
PJ 2007;278:447
Full Text
447 AAH weight management service An
enhanced version of AAH's weight management service has been launched, which
incorporates a risk assessment tool and runs over six months
PJ 2007;278:447
Full Text
447 Irish pharmacy regulation The
Pharmaceutical Society of Ireland, which has a wholly elected council, is to
be dissolved and replaced by a new society with a lay majority of 11 on its council
of 21 appointed members
PJ 2007;278:447
Full Text
448 Nottingham researchers win joint Queen's Award The
University of Nottingham School of Pharmacy and Molecular Profiles, a spin-off
company from the university, have received a joint innovation award in the Queen's
Awards for Enterprise
PJ 2007;278:448
Full Text
448 Plans to lift hospital
manufacturing standards Draft good practice guidelines
on small-scale manufacturing by hospital pharmacies will demand higher standards
than currently apply in many UK hospitals
PJ 2007;278:448
Full Text
448 European guidelines on first-in-man clinical
trials proposed Draft guidelines on first-in-man
clinical trials have been published by the European Medicines Agency (EMEA)
PJ 2007;278:448
Full Text
448 Senecio ban to be formalised Having
proposed a prohibition on unlicensed herbal medicines containing Senecio species
early in 2004, the Medicines and Healthcare products Regulatory Agency is now
consulting on proposed legislation which will implement the ban
PJ 2007;278:448
Full Text
448 Brain cancer alliance set up to develop
research in NW The School of Pharmacy and Pharmaceutical
Sciences at the University of Central Lancashire is part of a new strategic alliance
that will develop research programmes aimed at tackling brain cancers
PJ 2007;278:448
Full Text
449 First DPP-4 inhibitor
launched Sitagliptin, the first in a new class of oral anti-hyperglycaemic agents, has been launched by Merck, Sharp & Dohme
PJ 2007;278:449
Full Text
449 Ovarian cancer risk is increased for women
who use hormone replacement therapy Women who use
hormone replacement therapy are at increased risk of ovarian cancer, data collected
from the Million Women Study confirm
PJ 2007;278:449
Full Text
449 Paediatric depression trials A
new meta-analysis of paediatric trials supports the view that use of antidepressants
in children and adolescents for major depressive disorder, obsessive-compulsive
disorder (OCD) and non-OCD anxiety disorders increases the risk of suicidal behaviour.
However, the researchers argue that the risk is small and should not preclude
the careful use of these agents, which they say are effective, particularly for
non-OCD anxiety disorders
PJ 2007;278:449
Full Text
449 Poor knowledge of diabetes People
who have type 2 diabetes are often poorly informed about the condition, the results
of a survey published by the International Diabetes Federation this week suggest
PJ 2007;278:449
Full Text
449 Pharmacists can help fill gaps in care for
patients with depression There are considerable
gaps in the care provided for people with depression, which could be addressed
by improvements to the GP contract, according to a report published by mental
health charities Depression Alliance and SANE to coincide with depression awareness
week
PJ 2007;278:449
Full Text
R&D NEWS
450 Phase II data positive for HIV drug The
first in a new class of drugs to treat HIV has shown promise in a phase II trial
of patients with few remaining treatment options
PJ 2007;278:450
Full Text
450 Rapid genotyping assay could simplify warfarin
dose choice Genotypes affecting the dose-response
to warfarin can be accurately detected with a rapid genotyping assay that could
simplify dosage decisions, according to data reported at the American College
of Cardiology 2007 Scientific Sessions held in New Orleans last month
PJ 2007;278:450
Full Text
450 Retigabine reduces frequency of partial-onset
seizures Adjunctive therapy with the novel antiepileptic
drug retigabine reduces the frequency of partial-onset seizures for patients,
according to a recently published study
PJ 2007;278:450
Full Text
450 Tolvaptan improves heart failure symptoms
but not mortality Tolvaptan, given for the acute
treatment of patients admitted to hospital for heart failure, can improve patients'
symptoms but has no effect on long-term mortality or further hospital admissions,
results from two studies published
PJ 2007;278:450
Full Text
|
The
Pharmaceutical Journal